The Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value of USD 251.06 Million by 2030. In the projection period, the Global Market is forecasted ...

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

Chef Wolfgang Puck and his culinary team are back for the 31st annual Oscars Governors Ball — where they'll be serving his beloved staples alongside some inventive new dishes. (Read Puck's ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The puck did get close to his eye, but Ray didn't miss a beat. He stayed on to continue the broadcast before getting stitched. Ray is used to those sorts of bumps and bruises given his hockey history.

About the only pain they managed to inflict was to Buffalo broadcaster — and ex-Sabres enforcer — Rob Ray, who got hit in the head with an errant puck from Rangers defenseman Will Borgen.

A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...

In a December 2023 game, Ray was again struck — almost identically — with a puck right between the eyes. In both instances, he returned to action right away. Ray was inducted into the Sabres ...

South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about ...